HON:NASDAQHoneywell International Inc. Analysis
Data as of 2026-08-17 - not real-time
$233.96
Latest Price
4/10Risk
Risk Level: Medium
Executive Summary
At $233.96, Honeywell International Inc. shows a bullish moving-average alignment, with shorter averages sitting above longer ones. Over a rolling month the price has gained 1.8%. With RSI at 46.6 the momentum picture is neutral, alongside a bearish MACD signal. Price has been bracketed by support at $223.59 and resistance at $252.00.
Multiples put this in undervalued territory: 9.0 times earnings against the sector's 30.9. Analyst price targets sit 13.1% above the current price. Revenue is growing at 4.3% on a 21.6% profit margin. The 1.20% dividend yield looks covered by current payout levels.
On a 1-10 scale the risk profile lands at 4 — moderate. With 30-day volatility of 32.3%, a beta of 0.75 and a maximum drawdown of 17.0%, position sizing matters here. The wider market backdrop reads extreme greed at 96 on the fear-greed composite.
The horizons line up on buy — conviction 7 out of 10.
Multiples put this in undervalued territory: 9.0 times earnings against the sector's 30.9. Analyst price targets sit 13.1% above the current price. Revenue is growing at 4.3% on a 21.6% profit margin. The 1.20% dividend yield looks covered by current payout levels.
On a 1-10 scale the risk profile lands at 4 — moderate. With 30-day volatility of 32.3%, a beta of 0.75 and a maximum drawdown of 17.0%, position sizing matters here. The wider market backdrop reads extreme greed at 96 on the fear-greed composite.
The horizons line up on buy — conviction 7 out of 10.
Top Market Events
Guidance update and what it means for Honeywell International stock Honeywell International HON recently reaffirmed its...Honeywell International Inc. HON closed at $226.33 in the latest trading session, marking a +1.57% move from the prior...Honeywell International Inc. HON closed the most recent trading day at $223.42, moving +1.39% from the previous trading...
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 6/10
Key Factors
- Short-term moving averages stacked above long-term ones
- Trading above the 200-day average of 229.12
- MACD momentum is negative
Medium Term
1–3 yearsPositive
Model confidence: 6/10
Key Factors
- Short-term moving averages stacked above long-term ones
- P/E of 9.0 versus sector average of 30.9
- Trading above the 200-day average of 229.12
Long Term
> 3 yearsPositive
Model confidence: 7/10
Key Factors
- P/E of 9.0 versus sector average of 30.9
- Analyst targets imply +13.1% versus the current price
- Profit margin of 21.6% is healthy
Key Metrics & Analysis
Financial Health
Revenue Growth4.30%
Profit Margin21.58%
P/E Ratio9.0
ROE46.58%
ROA5.72%
Debt/Equity185.37
P/B Ratio4.0
Op. Cash Flow$5.1B
Free Cash Flow$2.6B
Industry P/E30.9
Technical Analysis
TrendBullish
RSI46.6
Support$223.59
Resistance$252.00
MA 20$240.22
MA 50$233.74
MA 200$229.12
MACDBearish
VolumeStable
Fear & Greed Index95.98
Valuation
Fair Value$46.56
Target Price$264.53
Upside/Downside13.06%
GradeUndervalued
TypeBlend
Dividend Yield1.20%
Risk Assessment
Beta0.75
Volatility32.32%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.